Telangana Bans Almont Kid Syrup Over Safety Concerns
Telangana bans Almont Kid Syrup after a central safety alert. Learn about the risks, the government's directive, and crucial steps for parents to ensure child safety.
Category : Search result: CDSCO report
Telangana Issues 'Stop Use' Notice for Almont-Kid Syrup
Telangana's Drugs Control Authority has advised the public to immediately stop using Almont-Kid Syrup and report it to authorities following a CDSCO alert. Safety first.
Telangana Bans Almont-Kid Syrup Over Toxic Contamination
Telangana DCA issues urgent alert to stop using Almont-Kid Syrup for children after CDSCO lab finds it adulterated with toxic Ethylene Glycol. Check batch numbers now.
Telangana Bans Almont-Kid Syrup Over Toxic Contamination
Telangana DCA issues urgent advisory to stop using Almont-Kid Syrup for children after finding toxic Ethylene Glycol. Check batch numbers and report possession immediately.
Telangana bans Almont Kid Syrup over contamination risk
Telangana bans Almont Kid Syrup after CDSCO alert finds contamination. Health officials order recall from all pharmacies. Parents urged to check medicine.
India Plans OTC Antibiotics Ban to Curb AMR Crisis
India's drug regulator proposes a major overhaul, including a ban on OTC antibiotic sales and an R&D push, to tackle antimicrobial resistance causing 267,000 deaths annually. Read the full plan.
Jobs Data This Week to Shape Fed's Interest Rate Decision
A crucial week of US jobs data, including ADP and JOLTS reports, will influence the Federal Reserve's upcoming interest rate decision. Markets await signals on labour market strength. Stay updated.
Govt Brings AI Cancer Detection Software Under Regulation
India's CDSCO now regulates AI-based cancer detection software as Class C medical devices, requiring approval and safety validation. Experts call the move timely for patient safety. #Healthcare #AI #India
Govt Rolls Out New Rules to Settle Minor Drug Violations
India introduces a formal mechanism for drug and medical device firms to settle minor regulatory violations by paying fines, aiming to reduce court burdens and focus on serious health risks. Learn how the new compounding rules work.
India Bans Nimesulide for Under-18s Over Safety Risks
India bans Nimesulide for those under 18, citing liver damage risks. This crucial step highlights the need for stricter drug regulation to protect public health. Read more.
RBI Report: Strong Economic Growth, Healthy Banks
The Reserve Bank of India's Financial Stability Report projects sustained strong growth for the Indian economy and highlights the sound health of commercial banks. Read the full analysis.
6mg Nicotine Pouches Seek Approval in India
Indian firms seek CDSCO nod to sell high-strength 6mg nicotine pouches as NRT, sparking fears of youth initiation and addiction. Experts warn of cardiovascular risks.
Drug Inspection Data Kept Secret, Public Safety at Risk?
India's drug regulator CDSCO refuses to disclose risk-based inspection details under RTI, sparking debate on transparency vs. commercial interests. Experts warn this secrecy endangers public health.
RBI: Banking Sector Resilient, NPA at Multi-Decade Low
RBI's latest report reveals robust health of Indian banking sector with 11.2% balance sheet growth, sustained profitability, and gross NPA ratio falling to 2.2%. Read the full analysis.
India's drug regulator cancels import licence of QR678 Neo
India's drug regulator CDSCO cancels the import licence of hair-loss product QR678 Neo for making false therapeutic claims while registered as a cosmetic. Learn the details and regulatory implications.
Govt Mulls 1-Year Extension for Pharma GMP Norms
The Indian government considers a one-year extension for MSMEs to comply with revised Schedule M GMP norms, aiming to prevent plant closures and safeguard its $50 billion pharma sector. Read more.
New CDSCO Rules for Solvent Labels After Child Deaths
India's drug regulator CDSCO mandates new labelling rules for solvent makers to prevent toxic chemicals from entering medicines. This follows the tragic deaths of at least 25 children in Madhya Pradesh. Read the full story.
Yale University faculty heavily skewed towards Democrats: Report
A new report reveals a stark political imbalance at Yale University, with over 82% of faculty leaning Democratic. Explore the implications for intellectual diversity and free speech on campus.
Medical Smartwatches Drive India's $4.2B Wearable Health Market
Smartwatches evolve from fitness trackers to certified health devices in India. With Apple & Samsung leading, the medical wearable market is projected to hit $4.2 billion by 2033. Read more.
Govt's Data Exclusivity Push May Hit Cheap Generic Drugs
The Indian government is considering data exclusivity for pharma, a move that could delay cheap generic drugs, impact India's global edge, and affect medicine access. Read the full analysis.
Himachal Leads Nation in Substandard Drugs: 49 Fail
Himachal Pradesh reports the highest number of substandard drug samples in India. 49 samples failed quality tests, raising serious concerns about public health and pharmaceutical regulation.
Pelicans vs Pacers: Injury Reports & Predictions for Dec 20
New Orleans Pelicans host Indiana Pacers on Dec 20. Get injury reports, starting lineups, game predictions, and where to watch this NBA clash. Can Pacers break road curse?
49 Himachal drug samples fail quality tests, recall ordered
Himachal drug controller directs firms to recall stock after 49 medicine samples fail quality tests. Substandard drugs include medication for fever, heart attacks, and diabetes. Learn which medicines to avoid.
The Scientific Bottlenecks Causing Slow Drug Approvals in India
India's drug approval process faces delays due to complex scientific hurdles in translational research. Experts explain the challenges and propose solutions for faster patient access to new treatments.
How to Dispute Credit Report Errors in India
Learn the crucial 4-step process to dispute credit report errors in India. Protect your credit score and ensure loan approvals by rectifying mistakes in your CIBIL report.
India Plans Perpetual Licenses for Medical Devices
India plans to replace 5-year medical device licenses with perpetual approvals and standardize lab testing to cut compliance costs and attract investment. Read more.
India's First AI-Based Smart Hemodialysis Machine Licence
Lords Mark Industries secures CDSCO licence for Class C AI Hemodialysis Machines, a major step for India's med-tech self-reliance. Read how this innovation impacts renal care.
Himachal Pharma Sector Faces Major Trust Crisis
Himachal Pradesh's pharmaceutical hub is in turmoil as 38 firms lose WHO-GMP certification, raising serious quality concerns. Discover the causes and impact.
QR Codes in Pharmacies to Boost India's Drug Safety Reporting
India mandates QR codes in all pharmacies for instant reporting of medicine side effects. This move aims to transform pharmacovigilance and make drug safety a public responsibility. Scan and report!
Trump's MRI Declared 'Perfectly Normal' by White House Doctor
White House releases President Donald Trump's MRI report, confirming the 79-year-old is in excellent health. Details from physician Dr. Sean Barbabella's memo inside. Read the full report.
Page 1 of 4